BlackRock Fund Advisors’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-1,640,990
Closed -$56.4M 3812
2014
Q4
$56.4M Sell
1,640,990
-431,036
-21% -$14.1M 0.01% 1380
2014
Q3
$61.9M Buy
2,072,026
+11,433
+0.6% +$242K 0.02% 1216
2014
Q2
$41.3M Sell
2,060,593
-76,118
-4% -$1.75M 0.01% 1526
2014
Q1
$58.1M Buy
2,136,711
+93,525
+5% +$2.48M 0.02% 1306
2013
Q4
$42.4M Buy
2,043,186
+9,439
+0.5% +$178K 0.01% 1506
2013
Q3
$37M Buy
2,033,747
+196,675
+11% +$3.55M 0.01% 1553
2013
Q2
$30.6M Buy
+1,837,072
New +$29.3M 0.01% 1542

Other funds holding AUXL

BlackRock Fund Advisors's AUXL Position: Q1 2015 in Review

BlackRock Fund Advisors sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q1 2015, closing a stake of 1,640,990 shares — an estimated $56.4M sold.

BlackRock Fund Advisors first reported a position in AUXL in Q2 2013 and held it in 7 quarters. The position peaked at $61.9M in Q3 2014. 1 fund tracked by Wall St. Rank holds AUXL as of Q1 2015.

  • BlackRock Fund Advisors reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • BlackRock Fund Advisors sold 1,640,990 AUXILIUM PHARAMCEUTICALS INC shares in Q1 2015, an estimated $56.4M.
  • BlackRock Fund Advisors first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • BlackRock Fund Advisors's AUXILIUM PHARAMCEUTICALS INC position peaked at $61.9M in Q3 2014.
  • 1 fund tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q1 2015.

Based on BlackRock Fund Advisors's 13F filing for Q1 2015, filed 13 May 2015.